Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed
2014 · Gastroenterology · 695 citations
https://doi.org/10.1053/j.gastro.2014.05.008
S
Shomron Ben‐Horin
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
579
Papers
16.8K
Citations
70
h-index
231
i10-index
Shomron Ben‐Horin is an academic researcher from Tel Aviv University. The author has contributed to research in topics: Inflammatory Bowel Disease & Microscopic Colitis & Immunodeficiency and Autoimmune Disorders. The author has an h-index of 70, co-authored 493 publications.
ORCID: 0000-0002-3984-4580Papers by this author
worksRandomized Controlled Trial: Subcutaneous vs Intravenous Infliximab CT-P13 Maintenance in Inflammatory Bowel Disease
2021 · Gastroenterology · 216 citations
https://doi.org/10.1053/j.gastro.2021.02.068
Systematic review with meta-analysis: loss of response and requirement of anti-TNFα dose intensification in Crohn’s disease
2017 · Journal of Gastroenterology · 179 citations
https://doi.org/10.1007/s00535-017-1324-3
Vedolizumab in IBD–Lessons From Real-world Experience; A Systematic Review and Pooled Analysis
2017 · Journal of Crohn s and Colitis · 147 citations
https://doi.org/10.1093/ecco-jcc/jjx143
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
2016 · Stem Cell Research & Therapy · 60 citations
https://doi.org/10.1186/s13287-016-0376-2
Towards AI-Augmented Clinical Decision-Making: An Examination of ChatGPT's Utility in Acute Ulcerative Colitis Presentations
2023 · The American Journal of Gastroenterology · 40 citations
https://doi.org/10.14309/ajg.0000000000002483
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat